These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 25625802)

  • 21. Associations between FGF21, osteonectin and bone turnover markers in type 2 diabetic patients with albuminuria.
    Xu L; Niu M; Yu W; Xia W; Gong F; Wang O
    J Diabetes Complications; 2017 Mar; 31(3):583-588. PubMed ID: 27916484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
    Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of sex on renal function decline in people with Type 2 diabetes.
    de Hauteclocque A; Ragot S; Slaoui Y; Gand E; Miot A; Sosner P; Halimi JM; Zaoui P; Rigalleau V; Roussel R; Saulnier PJ; Hadjadj Samy S;
    Diabet Med; 2014 Sep; 31(9):1121-8. PubMed ID: 24773061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes.
    Orlov S; Cherney DZ; Pop-Busui R; Lovblom LE; Ficociello LH; Smiles AM; Warram JH; Krolewski AS; Perkins BA
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1136-44. PubMed ID: 26092828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study.
    Fujita Y; Doi Y; Hamano T; Hatazaki M; Umayahara Y; Isaka Y; Tsubakihara Y
    Sci Rep; 2019 Oct; 9(1):14871. PubMed ID: 31619722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
    Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ
    Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between serum fibroblast growth factor 21 and diabetic nephropathy.
    Jian WX; Peng WH; Jin J; Chen XR; Fang WJ; Wang WX; Qin L; Dong Y; Su Q
    Metabolism; 2012 Jun; 61(6):853-9. PubMed ID: 22136913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes.
    Pilemann-Lyberg S; Hansen TW; Tofte N; Winther SA; Theilade S; Ahluwalia TS; Rossing P
    Diabetes Care; 2019 Jun; 42(6):1088-1094. PubMed ID: 30885950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
    Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Charlton-Menys V; DeMicco DA; Fuller JH;
    Am J Kidney Dis; 2009 Nov; 54(5):810-9. PubMed ID: 19540640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes.
    Jiang G; Luk AOY; Tam CHT; Xie F; Carstensen B; Lau ESH; Lim CKP; Lee HM; Ng ACW; Ng MCY; Ozaki R; Kong APS; Chow CC; Yang X; Lan HY; Tsui SKW; Fan X; Szeto CC; So WY; Chan JCN; Ma RCW;
    Kidney Int; 2019 Jan; 95(1):178-187. PubMed ID: 30415941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-normal serum uric acid predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus and preserved kidney function.
    Kim WJ; Kim SS; Bae MJ; Yi YS; Jeon YK; Kim BH; Song SH; Kim IJ; Kim YK
    J Diabetes Complications; 2014; 28(2):130-4. PubMed ID: 24438886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes.
    Xiao Y; Xu A; Law LS; Chen C; Li H; Li X; Yang L; Liu S; Zhou Z; Lam KS
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E54-8. PubMed ID: 22013098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of kidney-related outcomes in patients with type 2 diabetes.
    Jardine MJ; Hata J; Woodward M; Perkovic V; Ninomiya T; Arima H; Zoungas S; Cass A; Patel A; Marre M; Mancia G; Mogensen CE; Poulter N; Chalmers J;
    Am J Kidney Dis; 2012 Nov; 60(5):770-8. PubMed ID: 22694950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of serum fibroblast growth factor 21 with kidney function in a population-based Chinese cohort.
    Zhang R; Li Y; Zhou X; Zhang F; Li M; Zhang S; Zhang X; Wen X; Ji L
    Medicine (Baltimore); 2021 Dec; 100(50):e28238. PubMed ID: 34918690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between serum C-peptide level and diabetic retinopathy according to estimated glomerular filtration rate in patients with type 2 diabetes.
    Chung JO; Cho DH; Chung DJ; Chung MY
    J Diabetes Complications; 2015 Apr; 29(3):350-5. PubMed ID: 25623633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced Levels of Anti-Ageing Hormone Klotho Predict Renal Function Decline in Type 2 Diabetes.
    Fountoulakis N; Maltese G; Gnudi L; Karalliedde J
    J Clin Endocrinol Metab; 2018 May; 103(5):2026-2032. PubMed ID: 29509906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China.
    Li H; Dong K; Fang Q; Hou X; Zhou M; Bao Y; Xiang K; Xu A; Jia W
    J Hepatol; 2013 Mar; 58(3):557-63. PubMed ID: 23142063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-Terminal Fragment of Agrin (CAF): A Novel Marker for Progression of Kidney Disease in Type 2 Diabetics.
    Devetzis V; Daryadel A; Roumeliotis S; Theodoridis M; Wagner CA; Hettwer S; Huynh-Do U; Ploumis P; Arampatzis S
    PLoS One; 2015; 10(12):e0143524. PubMed ID: 26630274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques.
    An SY; Lee MS; Yi SA; Ha ES; Han SJ; Kim HJ; Kim DJ; Lee KW
    Diabetes Res Clin Pract; 2012 May; 96(2):196-203. PubMed ID: 22293928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.